FDA NDC Directory · JSON-LD · Markdown

ADENOSINE

NDC 51662-1632 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryAbbreviated NDA (generic) · App ANDA077133
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsADENOSINE (3 mg/mL)
Marketing started20230623
Package count1

External sources

Source: openFDA. Public-domain (CC0).